Pharma lobbying headed for record-breaking 2022, nonprofit says
Pharma’s lobbying expenses reached record heights last year — and according to the latest reports, the industry is on track to top those numbers in 2022.
In the first three quarters, pharma companies spent a total of $281 million on lobbying, according to Dan Auble, senior researcher at the nonprofit OpenSecrets. That’s approaching last year’s total of $350 million, making pharma the biggest spender in the health sector.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.